Studies of the molecular foundation of Alzheimer’s illness exemplify the more and more blurred distinction between primary and utilized biomedical analysis. The 4 genes up to now implicated in familial Alzheimer’s illness have every been proven to raise mind ranges of the self-aggregating amyloid-beta protein, main step by step to profound neuronal and glial alteration, synaptic loss and dementia. Progress in understanding this cascade has helped to determine particular therapeutic targets and gives a mannequin for elucidating different neurodegenerative problems.

Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative motion.
- The double-stranded RNA-dependent protein kinase PKR is a vital mediator of the antiproliferative and antiviral results exerted by interferons.
- Not solely is PKR an effector molecule on the mobile response to double-stranded RNA, nevertheless it additionally integrates indicators in response to Toll-like receptor activation, progress components, and numerous mobile stresses.
Recombinant Caenorhabditis Elegans clec-159 Protein (aa 1-207) |
VAng-Ly3238-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 2056.8 |
Description: Caenorhabditis Elegans C-type lectin domain-containing protein 159 (clec-159), recombination protein. |
Recombinant Caenorhabditis Elegans clec-161 Protein (aa 21-862) |
VAng-Ly3239-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Caenorhabditis Elegans C-type lectin domain-containing protein 161 (clec-161), partial, recombination protein. |
Recombinant Caenorhabditis Elegans clec-162 Protein (aa 18-313) |
VAng-Ly3240-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 4893.6 |
Description: Caenorhabditis Elegans C-type lectin domain-containing protein 162 (clec-162), recombination protein. |
Recombinant Caenorhabditis Elegans clec-162 Protein (aa 18-313) |
VAng-Ly3240-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 3474 |
Description: Caenorhabditis Elegans C-type lectin domain-containing protein 162 (clec-162), recombination protein. |
Recombinant Caenorhabditis Elegans clec-162 Protein (aa 18-313) |
VAng-Ly3240-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 2370 |
Description: Caenorhabditis Elegans C-type lectin domain-containing protein 162 (clec-162), recombination protein. |
Recombinant Caenorhabditis Elegans clec-91 Protein (aa 22-225) |
VAng-Ly3241-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 4200 |
Description: Caenorhabditis Elegans C-type lectin domain-containing protein 91 (clec-91), recombination protein. |
Recombinant Caenorhabditis Elegans clec-91 Protein (aa 22-225) |
VAng-Ly3241-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 2997.6 |
Description: Caenorhabditis Elegans C-type lectin domain-containing protein 91 (clec-91), recombination protein. |
Recombinant Caenorhabditis Elegans clec-91 Protein (aa 22-225) |
VAng-Ly3241-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 2040 |
Description: Caenorhabditis Elegans C-type lectin domain-containing protein 91 (clec-91), recombination protein. |
Human CLEC2B Antibody |
33430-05111 |
AssayPro |
150 ug |
EUR 313.2 |
Human CLEC4E Antibody |
32522-05111 |
AssayPro |
150 ug |
EUR 313.2 |
anti- CLEC11A antibody |
FNab01746 |
FN Test |
100µg |
EUR 606.3 |
Description: Antibody raised against CLEC11A |
anti- CLEC12B antibody |
FNab01747 |
FN Test |
100µg |
EUR 658.5 |
Description: Antibody raised against CLEC12B |
anti- CLEC14A antibody |
FNab01748 |
FN Test |
100µg |
EUR 658.5 |
Description: Antibody raised against CLEC14A |
anti- CLEC18A antibody |
FNab01749 |
FN Test |
100µg |
EUR 658.5 |
Description: Antibody raised against CLEC18A |
CLEC10A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0463402 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC11A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0463502 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC12A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0463602 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC12B sgRNA CRISPR Lentivector (Human) (Target 1) |
K0463702 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC14A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0463802 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC16A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0463902 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC17A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0464002 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC18A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0464102 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC18B sgRNA CRISPR Lentivector (Human) (Target 1) |
K0464202 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC18C sgRNA CRISPR Lentivector (Human) (Target 1) |
K0464302 |
ABM |
1.0 ug DNA |
EUR 184.8 |
anti- CLEC1A antibody |
FNab01750 |
FN Test |
100µg |
EUR 606.3 |
Description: Antibody raised against CLEC1A |
anti- CLEC2D antibody |
FNab01751 |
FN Test |
100µg |
EUR 606.3 |
Description: Antibody raised against CLEC2D |
anti- CLEC3B antibody |
FNab01752 |
FN Test |
100µg |
EUR 658.5 |
Description: Antibody raised against CLEC3B |
anti- CLEC4C antibody |
FNab01753 |
FN Test |
100µg |
EUR 606.3 |
Description: Antibody raised against CLEC4C |
anti- CLEC4D antibody |
FNab01754 |
FN Test |
100µg |
EUR 606.3 |
Description: Antibody raised against CLEC4D |
anti- CLEC4G antibody |
FNab01755 |
FN Test |
100µg |
EUR 606.3 |
Description: Antibody raised against CLEC4G |
anti- CLEC4G antibody |
FNab01756 |
FN Test |
100µg |
EUR 606.3 |
Description: Antibody raised against CLEC4G |
anti- CLEC4M antibody |
FNab01757 |
FN Test |
100µg |
EUR 606.3 |
Description: Antibody raised against CLEC4M |
anti- CLEC9A antibody |
FNab01758 |
FN Test |
100µg |
EUR 606.3 |
Description: Antibody raised against CLEC9A |
anti- CLEC10A/CD301 antibody |
FNab01745 |
FN Test |
100µg |
EUR 606.3 |
Description: Antibody raised against CLEC10A/CD301 |
CLEC1A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0461402 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC1B sgRNA CRISPR Lentivector (Human) (Target 1) |
K0461502 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC2A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0461602 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC2B sgRNA CRISPR Lentivector (Human) (Target 1) |
K0461702 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC2D sgRNA CRISPR Lentivector (Human) (Target 1) |
K0461802 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC2L sgRNA CRISPR Lentivector (Human) (Target 1) |
K0461902 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC3A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0462002 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC3B sgRNA CRISPR Lentivector (Human) (Target 1) |
K0462102 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC4A sgRNA CRISPR Lentivector (Human) (Target 1) |
K0462202 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC4C sgRNA CRISPR Lentivector (Human) (Target 1) |
K0462302 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC4D sgRNA CRISPR Lentivector (Human) (Target 1) |
K0462402 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC4E sgRNA CRISPR Lentivector (Human) (Target 1) |
K0462502 |
ABM |
1.0 ug DNA |
EUR 184.8 |
CLEC4F sgRNA CRISPR Lentivector (Human) (Target 1) |
K0462602 |
ABM |
1.0 ug DNA |
EUR 184.8 |
- In this evaluation, we offer an in depth image on how signaling downstream of PKR unfolds and what are the last word penalties for the cell destiny. PKR activation impacts each transcription and translation.
- PKR phosphorylation of the alpha subunit of eukaryotic initiation issue 2 outcomes in a blockade on translation initiation. However, PKR can’t keep away from the interpretation of some mobile and viral mRNAs bearing particular options in their 5′ untranslated areas.
- In addition, PKR impacts numerous transcriptional components resembling interferon regulatory issue 1, STATs, p53, activating transcription issue 3, and NF-kappaB. In specific, how PKR triggers a cascade of occasions involving IKK phosphorylation of IkappaB and NF-kappaB nuclear translocation has been intensively studied.
- At the mobile and organism ranges PKR exerts antiproliferative results, and it’s a key antiviral agent. Some extent of convergence in each results is that PKR activation outcomes in apoptosis induction.
- The extent and power of the antiviral motion of PKR are clearly understood by the findings that unrelated viral proteins of animal viruses have advanced to inhibit PKR motion by utilizing numerous methods. The case for the pathological penalties of the antiproliferative motion of PKR is much less understood, however therapeutic methods geared toward focusing on PKR are starting to supply promising outcomes.
- Tetrazolium salts have change into among the most generally used instruments in cell biology for measuring the metabolic exercise of cells starting from mammalian to microbial origin.
anti- CD80 antibody |
FNab09813 |
FN Test |
100µg |
EUR 658.5 |
Description: Antibody raised against CD80 |
anti- CD80 antibody |
FNab01500 |
FN Test |
100µg |
EUR 658.5 |
Description: Antibody raised against CD80 |
Human CD80/ T-lymphocyte activation antigen CD80 ELISA Kit |
E0441Hu |
Sunlong |
1 Kit |
EUR 675.6 |
Human CD80(T-lymphocyte activation antigen CD80) ELISA Kit |
EH0088 |
FN Test |
96T |
EUR 681.12 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 46.9pg/ml |
Mouse Anti-Human CD80 mAb |
CM015-100ug |
SAB |
100ug |
EUR 224.4 |
Mouse Anti-Human CD80 mAb |
CM015-25ug |
SAB |
25ug |
EUR 146.4 |
Human T- lymphocyte activation antigen CD80, CD80 ELISA KIT |
ELI-06511h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Anti-Hu CD80 PE |
1P-287-T025 |
ExBio |
25 tests |
EUR 168 |
Anti-Hu CD80 PE |
1P-287-T100 |
ExBio |
100 tests |
EUR 288 |
Anti-Hu CD80 APC |
1A-287-T025 |
ExBio |
25 tests |
EUR 168 |
Anti-Hu CD80 APC |
1A-287-T100 |
ExBio |
100 tests |
EUR 288 |
Anti-Hu CD80 FITC |
1F-287-T025 |
ExBio |
25 tests |
EUR 146.4 |
Anti-Hu CD80 FITC |
1F-287-T100 |
ExBio |
100 tests |
EUR 244.8 |
Anti-Hu CD80 PerCP |
PC-287-T025 |
ExBio |
25 tests |
EUR 168 |
Anti-Hu CD80 PerCP |
PC-287-T100 |
ExBio |
100 tests |
EUR 288 |
Anti-Hu CD80 Purified |
11-287-C025 |
ExBio |
0.025 mg |
EUR 124.8 |
Anti-Hu CD80 Purified |
11-287-C100 |
ExBio |
0.1 mg |
EUR 200.4 |
Anti-Ms CD80 Purified |
11-627-C100 |
ExBio |
0.1 mg |
EUR 135.6 |
Mouse Anti-Human CD80 mAbConjugated Antibody |
CCM015 |
SAB |
100ul |
EUR 476.4 |
Human T-lymphocyte activation antigen CD80 / B7-1 (CD80) ELISA Kit |
20-abx258485 |
Abbexa |
-
EUR 8534.40
-
EUR 4550.40
-
EUR 1054.80
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
Human T-lymphocyte activation antigen CD80 / B7-1 (CD80) ELISA Kit |
abx250225-96tests |
Abbexa |
96 tests |
EUR 801.6 |
Human CD80 shRNA Plasmid |
20-abx950663 |
Abbexa |
|
|
Human B7-1/CD80 |
MO15156 |
Neuromics |
100 ug |
EUR 700.8 |
Human B7-1/CD80 |
GT15255 |
Neuromics |
100 ug |
EUR 856.8 |
CD80 (Human) ELISA Kit |
K4172-100 |
Biovision |
each |
EUR 874.8 |
Anti-Hu CD80 PE-Cy7 |
T7-287-T025 |
ExBio |
25 tests |
EUR 184.8 |
Anti-Hu CD80 PE-Cy7 |
T7-287-T100 |
ExBio |
100 tests |
EUR 321.6 |
Anti-Hu CD80 PE-Cy5 |
T8-287-T025 |
ExBio |
25 tests |
EUR 168 |
Anti-Hu CD80 PE-Cy5 |
T8-287-T100 |
ExBio |
100 tests |
EUR 288 |
Anti-Hu CD80 Pacific Blue |
PB-287-T025 |
ExBio |
25 tests |
EUR 184.8 |
Anti-Hu CD80 Pacific Blue |
PB-287-T100 |
ExBio |
100 tests |
EUR 322.8 |
Anti-Hu CD80 Alexa Fluor700 |
A7-287-T025 |
ExBio |
25 tests |
EUR 184.8 |
Anti-Hu CD80 Alexa Fluor700 |
A7-287-T100 |
ExBio |
100 tests |
EUR 322.8 |
CD80 Human Recombinant Protein |
PROTP33681 |
BosterBio |
Regular: 5ug |
EUR 380.4 |
Description: CD80 Human Recombinant produced in Sf9 Insect cells is a single, glycosylated polypeptide chain containing 216 amino acids (35-242a.a.) and having a molecular mass of 24.9kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa).;CD80 is expressed with an 8 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques. |
CD80 Recombinant Protein (Human) |
RP051190 |
ABM |
100 ug |
Ask for price |
Human CellExp? CD80, human recombinant |
7383-10 |
Biovision |
each |
EUR 280.8 |
Human CellExp? CD80, human recombinant |
7383-50 |
Biovision |
each |
EUR 810 |
Mouse Anti-Human CD80, PE Conjugated mAb |
CM017-100T |
SAB |
100T |
EUR 441.6 |
Mouse Anti-Human CD80, PE Conjugated mAb |
CM017-25T |
SAB |
25T |
EUR 224.4 |
Mouse Anti-Human CD80, FITC Conjugated mAb |
CM016-100T |
SAB |
100T |
EUR 372 |
- With mammalian cells, fractionation research point out that the lowered pyridine nucleotide cofactor, NADH, is accountable for most MTT discount and that is supported by research with entire cells.
- MTT discount is related not solely with mitochondria, but additionally with the cytoplasm and with non-mitochondrial membranes together with the endosome/lysosome compartment and the plasma membrane.
- The internet optimistic cost on tetrazolium salts like MTT and NBT seems to be the predominant issue concerned in their mobile uptake by way of the plasma membrane potential. However, second era tetrazolium dyes that kind water-soluble formazans and require an intermediate electron acceptor for discount (XTT, WST-1 and to some extent, MTS), are characterised by a internet destructive cost and are due to this fact largely cell-impermeable.
- Considerable proof signifies that their discount happens on the cell floor, or on the stage of the plasma membrane by way of trans-plasma membrane electron transport. The implications of those new findings are mentioned in phrases of using tetrazolium dyes as indicators of cell metabolism and their purposes in cell biology.